Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
Molmir has raised $1.9M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Molmir's investors include Mitsubishi UFJ Capital, UntroD Capital, Higin Capital, Senshu Ikeda Capital, Nanto Capital Partners.
Molmir is headquartered in Nara, Japan.
Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
Molmir is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Molmir — Funding & Investors." VCBacked, April 22, 2026, https://www.vcbacked.co/company/molmir. Accessed September 30, 2026.
VCBacked. (2026). Molmir — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/molmir
{{cite web |title=Molmir — Funding & Investors |url=https://www.vcbacked.co/company/molmir |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated